The quality of life in neoadjuvant versus adjuvant therapy of esophageal cancer treatment trial (QUINTETT): Randomized parallel clinical superiority trial.
Richard A MalthanerEdward YuMichael SanataniDebra LewisAndrew WarnerA Rashid DarBrian P YaremkoJoel BiererDavid A PalmaDalilah FortinRichard I InculetEric FréchetteJacques RaphaelStewart GaedeSara KuruvillaJawaid YounusMark D VincentGeorge B RodriguesPublished in: Thoracic cancer (2022)
Trimodality therapy is challenging for patients with resectable esophageal cancer regardless of whether it is given before or after surgery. Newer and less toxic protocols are needed.